The development of precision medicine has been ongoing since the 1990s. From treatments for a few patients, we are today faced with the widespread introduction of precision medicine in new parts of healthcare.

A Public-Private Partnership focusing on implementation of precision health in cancer in Sweden is under establishment. SweConnect will be project managed by Vision Zero Cancer in collaboration with Genomic Medicine Sweden (GMS).

Implementation of precision cancer medicine and economic evaluation for Health Technology Assessment (HTA) – what are the challenges and how do we address them?

We are looking forward to participating at the Nordic Precision Cancer Medicine conference in Oslo during next week.

FOCU.SE is an initiative by Testbed Sweden Precision Health Cancer, founded by Vision Zero Cancer, Genomic Medicine Sweden and SciLifeLab, involving regulators, policymakers, payers, researchers, healthcare providers, patient advocates, and industry to drive the implementation of precision health in cancer care.

Folkhälsodalen (The Public Health Valley) is a meeting place for decision-makers, professionals, industry, and researchers in public health, medicine, and healthcare. An initiative of Reform Society. The seminars are in Swedish.

Testbed Sweden Precision Health Cancer is a national collaborative project for the design and method development of precision medicine treatment studies

Folkhälsodalen (The Public Health Valley) is a meeting place for decision-makers, professionals, industry, and researchers in public health, medicine, and healthcare. An initiative of Reform Society. The seminars are in Swedish.

The aim of Europe’s Beating Cancer Plan is to tackle the entire disease pathway. Over the coming years, it will focus on research and innovation, tap into the potential that digitalisation and new technologies offer, and mobilise financial instruments to support Member States.

One size fits all is no longer applicable. Precision medicine has made several advancements in recent years. Rapid development in research and technology is creating conditions for a transformation of the system. With these developments come challenges and consequences – but which ones?